Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential platinum then paclitaxel-based chemotherapy for advanced inoperable epithelial non-mucinous peritoneal malignancy
ISRCTN24742183Phase 2Completed
- Sponsor
- University of Warwick
- Start
- Dec 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
01
Overview
Phase 2, open-label trial of carboplatin, paclitaxel and gemcitabine in ovarian cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC) and 1 more (2 arms), sponsored by University of Warwick. Primary endpoint: Completion of 12 cycles of chemotherapy. Started Dec 2007; status: completed.
02
Drugs
carboplatinpaclitaxelgemcitabine
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)ovarian carcinosarcoma (OCS)
Beyond the preview
Go deeper on ISRCTN24742183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN24742183.